acebutolol has been researched along with Arrhythmias, Cardiac in 46 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acebutolol was compared to placebo, propranolol, and quinidine for the suppression of chronic ventricular arrhythmia in three double-blind, randomized crossover studies." | 9.05 | Comparison of acebutolol with propranolol, quinidine, and placebo: results of three multicenter arrhythmia trials. ( Chandraratna, PA, 1985) |
| "The effect of intravenous acebutolol on supraventricular arrhythmias was evaluated in 20 patients, 5 with chronic obstructive pulmonary disease." | 9.04 | Acebutolol in supraventricular arrhythmias. ( Aronow, WS; Lurie, M; Turbow, M; Van Camp, S; Whittaker, K, 1979) |
| "To evaluate the antiarrhythmic efficacy of the new beta adrenergic blocking agent acebutolol, 15 monitored patients with supraventricular arrhythmias received, in double-blind fashion, an intravenous infusion of either acebutolol or saline solution after a control period." | 9.04 | Effective treatment of supraventricular arrhythmias with acebutolol. ( Most, AS; Tatelbaum, R; Williams, DO, 1979) |
| "The effect of the beta-blocking drug acebutolol on the severity of cardiac arrhythmias and the incidence of exercise-induced arrhythmias was studied in 15 patients with chronic coronary artery disease using ambulatory Holter monitoring and bicycle ergometry." | 7.66 | The effect of acebutolol on cardiac arrhythmias in patients with chronic coronary artery disease. ( Burckhardt, D; Raeder, EA, 1980) |
| " When arrhythmia was induced in dogs with ouabain, the plasma adrenaline and noradrenaline levels increased to 220 +/- 109 and 392 +/- 84 pg/ml, respectively, from the basal levels of 44 +/- 24 and 140 +/- 43 pg/ml." | 7.66 | Effect of acebutolol on plasma catecholamine concentrations in anesthetized dogs with ouabain-induced arrhythmias and its direct actions in vitro on the adrenal medulla. ( Iwatsuki, K; Nagayama, T; Nakai, T; Ode, H; Okuda, C; Sakio, H; Yamada, R, 1983) |
| "To assess the effects of intravenously administered acebutolol (1-20 mg every 4 hours for 24 hours) on cardiac rhythm and performance, we studied 72 patients with evolving myocardial infarction." | 7.66 | Reduction of early ventricular arrhythmia by acebutolol in patients with acute myocardial infarction. ( Ahumada, GG; Ambos, HD; Jaffe, AS; Karlsberg, RP; Roberts, R; Sobel, BE, 1979) |
| "Acebutolol (M & B 17,803 A), a new cardioselective beta-adrenergic blocking agent, was given intravenously to 20 selected patients with various cardiac arrhythmias." | 7.65 | Properties of acebutolol in twenty patients with cardiac arrhythmias. ( Biron, P; Lapointe, L; Nadeau, R; Proulx, A; Tremblay, G, 1975) |
| "Acebutolol was discontinued because of side effects in one patient only." | 6.65 | Acebutolol therapy for ventricular arrhythmia. A randomized placebo-controlled double-blind multicenter study. ( Aronow, WS; Chandraratna, PA; De Soyza, N; Laddu, AR; Shapiro, W; Thompson, CH, 1982) |
| "Acebutolol is a cardioselective beta-adrenoceptor blocking drug possessing both partial agonist (intrinsic sympathomimetic) and membrane stabilising activity." | 6.37 | Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia. ( Singh, BN; Thoden, WR; Ward, A, 1985) |
| "Acebutolol was compared to placebo, propranolol, and quinidine for the suppression of chronic ventricular arrhythmia in three double-blind, randomized crossover studies." | 5.05 | Comparison of acebutolol with propranolol, quinidine, and placebo: results of three multicenter arrhythmia trials. ( Chandraratna, PA, 1985) |
| "The effect of intravenous acebutolol on supraventricular arrhythmias was evaluated in 20 patients, 5 with chronic obstructive pulmonary disease." | 5.04 | Acebutolol in supraventricular arrhythmias. ( Aronow, WS; Lurie, M; Turbow, M; Van Camp, S; Whittaker, K, 1979) |
| "To evaluate the antiarrhythmic efficacy of the new beta adrenergic blocking agent acebutolol, 15 monitored patients with supraventricular arrhythmias received, in double-blind fashion, an intravenous infusion of either acebutolol or saline solution after a control period." | 5.04 | Effective treatment of supraventricular arrhythmias with acebutolol. ( Most, AS; Tatelbaum, R; Williams, DO, 1979) |
| "During 10 years of clinical use involving almost 3 million patient-years, acebutolol has become established as a remarkably safe and well-tolerated beta-blocking agent, effective in treating essential hypertension and cardiac arrhythmias." | 4.77 | Acebutolol: ten years of experience. ( De Bono, G; Kaye, CM; Roland, E; Summers, AJ, 1985) |
| "The effect of the beta-blocking drug acebutolol on the severity of cardiac arrhythmias and the incidence of exercise-induced arrhythmias was studied in 15 patients with chronic coronary artery disease using ambulatory Holter monitoring and bicycle ergometry." | 3.66 | The effect of acebutolol on cardiac arrhythmias in patients with chronic coronary artery disease. ( Burckhardt, D; Raeder, EA, 1980) |
| " When arrhythmia was induced in dogs with ouabain, the plasma adrenaline and noradrenaline levels increased to 220 +/- 109 and 392 +/- 84 pg/ml, respectively, from the basal levels of 44 +/- 24 and 140 +/- 43 pg/ml." | 3.66 | Effect of acebutolol on plasma catecholamine concentrations in anesthetized dogs with ouabain-induced arrhythmias and its direct actions in vitro on the adrenal medulla. ( Iwatsuki, K; Nagayama, T; Nakai, T; Ode, H; Okuda, C; Sakio, H; Yamada, R, 1983) |
| "To assess the effects of intravenously administered acebutolol (1-20 mg every 4 hours for 24 hours) on cardiac rhythm and performance, we studied 72 patients with evolving myocardial infarction." | 3.66 | Reduction of early ventricular arrhythmia by acebutolol in patients with acute myocardial infarction. ( Ahumada, GG; Ambos, HD; Jaffe, AS; Karlsberg, RP; Roberts, R; Sobel, BE, 1979) |
| "A study was carried out in 20 ambulatory patients with various heart diseases and different forms of cardiac arrhythmias to evaluate the anti-arrhythmic effect of acebutolol when given orally(400 mg/day)." | 3.65 | Anti-arrhythmic properties of acebutolol (Bay c 7705), a new cardioselective beta-adrenergic blocking agent: a preliminary report. ( Burckhardt, K; Ebner, F; Raeder, E, 1977) |
| " In particular, the anti-ouabain arrhythmia properties were not dependent upon beta-blocking potency." | 3.65 | [Pharmacology of acebutolol in animals]. ( Basil, B, 1975) |
| "Acebutolol (M & B 17,803 A), a new cardioselective beta-adrenergic blocking agent, was given intravenously to 20 selected patients with various cardiac arrhythmias." | 3.65 | Properties of acebutolol in twenty patients with cardiac arrhythmias. ( Biron, P; Lapointe, L; Nadeau, R; Proulx, A; Tremblay, G, 1975) |
| "Acebutolol is a safe and efficacious drug for the prevention of arrhythmias following coronary surgery." | 2.66 | Prevention by acebutolol of rhythm disorders following coronary bypass surgery. ( Collignon, P; Kulbertus, H; Larbuisson, R; Limet, R; Materne, P, 1985) |
| "Acebutolol appears to be an effective and well-tolerated antiarrhythmic agent in the treatment of VEB and higher grades of ventricular ectopy." | 2.65 | Reduction of ventricular ectopic beats with oral acebutolol: a double-blind, randomized crossover study. ( Dhurandhar, R; Dietrich, P; Hungate, EJ; Laddu, A; Lee, G; Lui, HK; Mason, DT, 1983) |
| "Acebutolol was discontinued because of side effects in one patient only." | 2.65 | Acebutolol therapy for ventricular arrhythmia. A randomized placebo-controlled double-blind multicenter study. ( Aronow, WS; Chandraratna, PA; De Soyza, N; Laddu, AR; Shapiro, W; Thompson, CH, 1982) |
| "Acebutolol was well tolerated by the three patients with chronic obstructive pulmonary disease." | 2.65 | Treatment of premature ventricular complexes with acebutolol. ( Aronow, WS; Lurie, M; Turbow, M; Van Camp, S; Whittaker, K, 1979) |
| "Acebutolol is a cardioselective beta-adrenoceptor blocking drug possessing both partial agonist (intrinsic sympathomimetic) and membrane stabilising activity." | 2.37 | Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia. ( Singh, BN; Thoden, WR; Ward, A, 1985) |
| "Acebutolol has both antihypertensive and antiarrhythmic effects." | 1.27 | Pharmacologic properties of acebutolol: relationship of hydrophilicity to central nervous system penetration. ( Abernethy, DR; Arendt, RM; Greenblatt, DJ, 1985) |
| "Pretreatment with acebutolol, 15 min before starting reperfusion, markedly reduced the arrhythmias." | 1.26 | Cardiovascular effects of acebutolol following coronary artery occlusion and reperfusion in anaesthetized dog. ( Chernecki, W; Das, PK; Dhalla, NS; Sharma, GP, 1978) |
| " Our study suggests: 2 The acetyl metabolite was present in concentrations greater than those of acebutolol at all times during the dosing interval in all seven subjects." | 1.26 | Acebutolol metabolite plasma concentration during chronic oral therapy. ( Harrison, DC; Meffin, PJ; Ricks, WB; Winkle, RA, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 45 (97.83) | 18.7374 |
| 1990's | 1 (2.17) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basil, B | 2 |
| Clark, JR | 1 |
| Coffee, EC | 1 |
| Jordon, R | 1 |
| Loveless, AH | 1 |
| Pain, DL | 1 |
| Wooldridge, KR | 1 |
| Burckhardt, D | 1 |
| Raeder, EA | 1 |
| Moses, JW | 1 |
| Borer, JS | 1 |
| Frick, MH | 1 |
| Kala, R | 1 |
| Rosselot, E | 1 |
| Rochette, L | 1 |
| Didier, JP | 1 |
| Moreau, D | 1 |
| Bralet, J | 1 |
| Opie, LH | 1 |
| Shapiro, W | 2 |
| Park, J | 1 |
| Koch, GG | 1 |
| Singh, SN | 1 |
| DiBianco, R | 1 |
| Davidov, ME | 1 |
| Gottdiener, JS | 1 |
| Johnson, WL | 1 |
| Laddu, AR | 3 |
| Fletcher, RD | 1 |
| Yenes, A | 1 |
| Chamorro, H | 1 |
| González, G | 1 |
| Nakai, T | 2 |
| Sakio, H | 1 |
| Nagayama, T | 1 |
| Ode, H | 1 |
| Yamada, R | 2 |
| Okuda, C | 1 |
| Iwatsuki, K | 1 |
| Latini, R | 1 |
| Achilli, L | 1 |
| Lombi, V | 1 |
| Caporicci, D | 1 |
| de Soyza, N | 3 |
| Kane, JJ | 1 |
| Murphy, ML | 1 |
| Doherty, JE | 1 |
| Bissett, JK | 1 |
| Benchimol, A | 1 |
| Desser, KB | 1 |
| Santoso, T | 1 |
| Nursyirwan, EF | 1 |
| Trisnohadi, HB | 1 |
| Manurung, D | 1 |
| Rahman, AM | 1 |
| Abdurahman, N | 1 |
| Lui, HK | 1 |
| Lee, G | 1 |
| Dhurandhar, R | 1 |
| Hungate, EJ | 1 |
| Laddu, A | 1 |
| Dietrich, P | 1 |
| Mason, DT | 1 |
| Aronow, WS | 4 |
| Wong, R | 1 |
| Plasencia, G | 1 |
| Landa, D | 1 |
| Turbow, M | 3 |
| Chandraratna, PA | 2 |
| Thompson, CH | 1 |
| Schroeder, JS | 1 |
| Van Camp, S | 2 |
| Whittaker, K | 2 |
| Lurie, M | 2 |
| Williams, DO | 1 |
| Tatelbaum, R | 1 |
| Most, AS | 1 |
| Ahumada, GG | 1 |
| Karlsberg, RP | 1 |
| Jaffe, AS | 1 |
| Ambos, HD | 1 |
| Sobel, BE | 1 |
| Roberts, R | 1 |
| Dietz, A | 1 |
| Walter, J | 1 |
| Wiese, K | 1 |
| Yusa, T | 1 |
| Matsukawa, S | 1 |
| Shima, T | 1 |
| Anderson, JL | 1 |
| Harrison, DC | 2 |
| Meffin, PJ | 2 |
| Winkle, RA | 2 |
| Chernecki, W | 1 |
| Das, PK | 1 |
| Dhalla, NS | 1 |
| Sharma, GP | 1 |
| Burckhardt, K | 1 |
| Raeder, E | 1 |
| Ebner, F | 1 |
| Ricks, WB | 1 |
| Suzuki, M | 1 |
| Terukina, M | 1 |
| Akamatsu, T | 1 |
| Suzuki, K | 1 |
| Biron, P | 2 |
| Proulx, A | 2 |
| Lapointe, L | 1 |
| Nadeau, R | 2 |
| Tremblay, G | 2 |
| O'Reilly, M | 1 |
| Puddu, PE | 1 |
| Jouve, R | 1 |
| Langlet, F | 1 |
| Guillen, JC | 1 |
| Fornaris, M | 1 |
| Torresani, J | 1 |
| Reale, A | 1 |
| Abernethy, DR | 1 |
| Arendt, RM | 1 |
| Greenblatt, DJ | 1 |
| De Bono, G | 1 |
| Kaye, CM | 1 |
| Roland, E | 1 |
| Summers, AJ | 1 |
| Sugiyama, S | 1 |
| Hattori, M | 1 |
| Miyazaki, Y | 1 |
| Nagai, S | 1 |
| Ozawa, T | 1 |
| Roelofse, JA | 1 |
| Shipton, EA | 1 |
| de V Joubert, JJ | 1 |
| Luus, HG | 1 |
| de Roquefeuil, F | 1 |
| Goupil, C | 1 |
| Fergusson, NV | 1 |
| Dalgleish, JG | 1 |
| Saunders, DA | 1 |
| Singh, BN | 1 |
| Thoden, WR | 1 |
| Ward, A | 1 |
| Materne, P | 1 |
| Larbuisson, R | 1 |
| Collignon, P | 1 |
| Limet, R | 1 |
| Kulbertus, H | 1 |
4 reviews available for acebutolol and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Ca | 1981 |
Chronic use of acebutolol in the treatment of cardiac arrhythmias.
Topics: Acebutolol; Arrhythmias, Cardiac; Chronic Disease; Clinical Trials as Topic; Humans | 1991 |
Acebutolol: ten years of experience.
Topics: Acebutolol; Adrenergic beta-Antagonists; Age Factors; Animals; Arrhythmias, Cardiac; Blood Circulati | 1985 |
Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.
Topics: Acebutolol; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Vessels; B | 1985 |
14 trials available for acebutolol and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Variability of spontaneous and exercise-induced ventricular arrhythmias in the absence and presence of treatment with acebutolol or quinidine.
Topics: Acebutolol; Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Circadian Rhythm; Clini | 1982 |
Comparison of acebutolol and propranolol for treatment of chronic ventricular arrhythmia: a placebo-controlled, double-blind, randomized crossover study.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Prema | 1982 |
Reduction of ventricular ectopic beats with oral acebutolol: a double-blind, randomized crossover study.
Topics: Acebutolol; Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Double-Blind Method; Electrocar | 1983 |
Effect of acebutolol and propranolol on premature ventricular complexes.
Topics: Acebutolol; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; Female; Heart | 1980 |
Acebutolol therapy for ventricular arrhythmia. A randomized placebo-controlled double-blind multicenter study.
Topics: Acebutolol; Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Dose-Response Relationship, | 1982 |
Newer antiarrhythmic agents for patients with coronary artery disease.
Topics: Acebutolol; Adult; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; | 1978 |
Acebutolol in supraventricular arrhythmias.
Topics: Acebutolol; Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; Heart | 1979 |
Effective treatment of supraventricular arrhythmias with acebutolol.
Topics: Acebutolol; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Double-Blin | 1979 |
[Anti-arrhthmic effect of a new beta blocker in long term therapy of ambulatory patients].
Topics: Acebutolol; Adult; Ambulatory Care; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation; F | 1977 |
Treatment of premature ventricular complexes with acebutolol.
Topics: Acebutolol; Adult; Aged; Arrhythmias, Cardiac; Double-Blind Method; Drug Evaluation; Humans; Injecti | 1979 |
Acebutolol and oral surgery: plasma levels following a single oral dose.
Topics: Acebutolol; Administration, Oral; Adult; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as To | 1985 |
Acebutolol.
Topics: Acebutolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Heart Ventricles; Humans; Hypertension; | 1985 |
Prevention by acebutolol of rhythm disorders following coronary bypass surgery.
Topics: Acebutolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease | 1985 |
Comparison of acebutolol with propranolol, quinidine, and placebo: results of three multicenter arrhythmia trials.
Topics: Acebutolol; Adult; Aged; Arrhythmias, Cardiac; Double-Blind Method; Female; Humans; Male; Middle Age | 1985 |
28 other studies available for acebutolol and Arrhythmias, Cardiac
| Article | Year |
|---|---|
A new series of cardioselective adrenergic beta-receptor blocking compounds. 1-(2-Acyl-4-acylaminophenoxy)-3-isopropylaminopropan-2-ols.
Topics: Adrenergic beta-Antagonists; Anilides; Animals; Arrhythmias, Cardiac; Cats; Dogs; Heart Rate; Isopro | 1976 |
The effect of acebutolol on cardiac arrhythmias in patients with chronic coronary artery disease.
Topics: Acebutolol; Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Coronary Disease; Electrocardio | 1980 |
Antiarrhythmic significance of dosing intervals in beta receptor blocking therapy of hypertension with acebutolol.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Arrhythmias, Cardiac; Blood Pressure; Double-Blind M | 1981 |
[Use of beta blockaders in arrhythmias and ischemic heart disease].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Catechol | 1982 |
Role of beta-adrenoreceptor antagonism in the prevention of reperfusion ventricular arrhythmias: effects of acebutolol, atenolol, and d-propranolol on isolated working rat hearts subject to myocardial ischemia and reperfusion.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Atenolol; Cardiac Output; Co | 1984 |
[Intravenous acebutolol in supraventricular arrhythmias and ventricular extrasystole. Experience in 22 cases].
Topics: Acebutolol; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Cardiac Complexes, Premature; Electro | 1984 |
Effect of acebutolol on plasma catecholamine concentrations in anesthetized dogs with ouabain-induced arrhythmias and its direct actions in vitro on the adrenal medulla.
Topics: Acebutolol; Adrenal Medulla; Anesthesia; Animals; Arrhythmias, Cardiac; Catecholamines; Dogs; Female | 1983 |
[Plasma catecholamine concentrations in ouabain-induced arrhythmia during acebutolol administration].
Topics: Acebutolol; Adrenal Medulla; Animals; Arrhythmias, Cardiac; Catecholamines; Dogs; In Vitro Technique | 1984 |
[Efficacy of acebutolol in hypertensive and arrhythmia patients].
Topics: Acebutolol; Adult; Arrhythmias, Cardiac; Drug Evaluation; Female; Humans; Hypertension; Male; Middle | 1984 |
The long-term suppression of ventricular arrhythmia by oral acebutolol in patients with coronary artery disease.
Topics: Acebutolol; Administration, Oral; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Heart Rate | 1980 |
New drugs for treating cardiac arrhythmias.
Topics: Acebutolol; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Encainide | 1981 |
Suppression of ventricular arrhythmia by acebutolol.
Topics: Acebutolol; Adult; Arrhythmias, Cardiac; Blood Pressure; Drug Evaluation; Electrocardiography; Femal | 1983 |
Reduction of early ventricular arrhythmia by acebutolol in patients with acute myocardial infarction.
Topics: Acebutolol; Acute Disease; Adult; Aged; Arrhythmias, Cardiac; Creatine Kinase; Electrocardiography; | 1979 |
[Hemodynamic and antiarrythmic actions of acebutolol in clinical anesthesia (author's transl)].
Topics: Acebutolol; Adult; Aged; Anesthesia; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Hemodynam | 1977 |
Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
Topics: Acebutolol; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Bretylium Compounds | 1978 |
Cardiovascular effects of acebutolol following coronary artery occlusion and reperfusion in anaesthetized dog.
Topics: Acebutolol; Anesthesia; Animals; Arrhythmias, Cardiac; Coronary Disease; Dogs; Electrocardiography; | 1978 |
Anti-arrhythmic properties of acebutolol (Bay c 7705), a new cardioselective beta-adrenergic blocking agent: a preliminary report.
Topics: Acebutolol; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Female; Heart | 1977 |
Acebutolol metabolite plasma concentration during chronic oral therapy.
Topics: Acebutolol; Administration, Oral; Arrhythmias, Cardiac; Humans; Time Factors | 1977 |
[Antiarrhythmic effects and blood level of acebutolol as for oral administration (author's transl)].
Topics: Acebutolol; Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; | 1977 |
[Pharmacology of acebutolol in animals].
Topics: Acebutolol; Animals; Arrhythmias, Cardiac; Blood Pressure; Chemoreceptor Cells; Chloroform; Dogs; Dr | 1975 |
Properties of acebutolol in twenty patients with cardiac arrhythmias.
Topics: Acebutolol; Adult; Aged; Arrhythmias, Cardiac; Female; Humans; Infusions, Parenteral; Male; Middle A | 1975 |
Prevention of postischaemic ventricular fibrillation by long term beta adrenoceptor blockade with acebutolol in the anaesthetised dog.
Topics: Acebutolol; Administration, Oral; Animals; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Coron | 1986 |
Pharmacologic properties of acebutolol: relationship of hydrophilicity to central nervous system penetration.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Blood-Brain Barrier; Cats; C | 1985 |
Mechanism of antiarrhythmic action of beta-blocking agents.
Topics: Acebutolol; Acyl Coenzyme A; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Calcium; Ca | 1985 |
The cardiovascular response to tracheal intubation during anaesthesia for oral surgical procedures. Effects of labetalol, acebutolol and lignocaine on cardiac rhythm.
Topics: Acebutolol; Adult; Anesthesia, Dental; Anesthesia, Intravenous; Arrhythmias, Cardiac; Female; Heart | 1986 |
[Sectral].
Topics: Acebutolol; Angina Pectoris; Arrhythmias, Cardiac; Humans; Hypertension | 1985 |
Acebutolol for premature ventricular contractions: short- and long-term effects.
Topics: Acebutolol; Adult; Aged; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Time Factors | 1985 |
[Anti-arrhythmic and anti-anginal properties of acebutolol].
Topics: Acebutolol; Adrenergic beta-Antagonists; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardi | 1974 |